Muddy Waters takes short position in drugmaker Chinook - report

Chinook Therapeutics

16/05/2023 15:00

LONDON, May 16 (Reuters) -    Shortseller Muddy Waters
said on Tuesday it had taken a short position in the stock of
the pharmaceutical company, Chinook Therapeutics Inc  KDNY.O . 
    Muddy Waters said in a report that it was "highly unlikely"
that Chinook's treatment for chronic kidney disease, atrasentan,
would receive regulatory approval by the U.S. Food and Drug
Administration (FDA). 
    Reuters has contacted the company for comment.

 (Reporting by Nell Mackenzie)
 ((Nell.Mackenzie@thomsonreuters.com; https://twitter.com/nellmooney;))